Conflict of Interest: Dr. Blumenfeld reports no conflict of interest in relation to nerve blocks. He does have consulting agreements, research grants, and/or speaking contracts with Allergan, Merz, Ipsen, Forrest, Pfizer, Posen, Zogenix, MAP Pharm, Impax. Dr. Ashkenazi – reports no conflicts. Dr. Napchan – received honoraria from GlaxoSmithKline and Zogenix. Dr. Bender – member of the advisory board of Nautilus Neurosciences and a member of the speakers bureau of IMPAX Pharmaceuticals. Dr. Klein – reports no conflict of interest. Dr. Berliner – received honoraria from Allergan, Nautilus, and Zogenix. Dr. Ailani – reports no conflicts. Dr. Schim – member of the advisory boards of Allergan, Zogenix, and MAP – honoraria: Allergan, Zogenix, Pfizer. Dr. Friedman – reports no conflicts. Dr. Charleston – reports no conflicts. Dr. Young – received funding for travel and speaker honoraria from Allergan, GlaxoSmithKline, Iroco, Merck, and Zogenix; serves as a consultant for Merz Pharmaceuticals; received research support from AGA Medical, Advanced Bionics, Advanced Neuromodulation Systems, Allergan, Capnia, Chorus (Lilly), Eli Lilly, Endo Pharmaceuticals, GlaxoSmithKline, MAP Pharmaceuticals, Medtronic, Minster, National Institute of Neurological Disorders and Stroke/National Institutes of Health, NuPathe, and Valeant; and receives royalties from Migraine and Other Headaches (2004) published by Demos Medical. Dr. Robertson – reports no conflicts. Dr. Dodick – research grants from Advanced Neurostimulation Systems, Boston Scientific, Mayo Clinic, Medtronic, NINDS/NIH, St. Jude Medical Inc. Honoraria: Alexza, Allergan, Kowa, ATI, Boston Scientific, Bristol Myers Squibb, Coherex, Eli Lilly & Company, Endo, HS Luncbeck, MAP Pharmaceuticals, Merck Serono, Medtronic, Inc., Minster, Nautilus, Neuralieve, Neuraxon, NuPathe, Inc., Novartis, Pfizer, SmithKlineBeecham. Speakers bureau for: Annenberg Center, CogniMed, Intramed, SAGE Publishing, Lippincott Williams and Wilkins, Oxford University Press, Cambridge University Press, Miller Medical. Dr. Silberstein – honoraria: Amgen, AGA, Allergan, Boston Scientific, Capnia, Coherex, Colucid, GlaxoSmithKline, Lilly, MAP, Medtronic, Merck, NINDS, Nupathe, Novartis, Pfizer, St. Jude Medical, Valeant. He is part of the speakers bureau for Endo Pharmaceuticals, GlaxoSmithKline, Merck. Research grants have been received from: AGA, Allergan, Amgen, Boston Scientific, Capnia, Coherex, Endo Pharmaceuticals, GlaxoSmithKline, Lilly, Map, Medtronic, Merck, Minister, Neuralieve, Novartis, NINDS, NuPathe, Opt-Nose, Pfizer, St. Jude Medical, Valeant Pharmaceuticals. Dr. Robbins – reports no conflicts.
Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches – A Narrative Review
Article first published online: 13 FEB 2013
© 2013 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 53, Issue 3, pages 437–446, March 2013
How to Cite
Blumenfeld, A., Ashkenazi, A., Napchan, U., Bender, S. D., Klein, B. C., Berliner, R., Ailani, J., Schim, J., Friedman, D. I., Charleston, L., Young, W. B., Robertson, C. E., Dodick, D. W., Silberstein, S. D. and Robbins, M. S. (2013), Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches – A Narrative Review. Headache: The Journal of Head and Face Pain, 53: 437–446. doi: 10.1111/head.12053
This publication is neither an official position paper nor an official guideline from the American Headache Society.
- Issue published online: 13 MAR 2013
- Article first published online: 13 FEB 2013
- Manuscript Accepted: 2 MAY 2012
- 1Peripheral procedures: Nerve blocks, peripheral neurostimulation, and Botulinum neurotoxin injections. In: Silberstein S , Lipton R , Dodick D , eds. Wolff's Headache and Other Head Pain. New York: Oxford University Press; 2007:767-792., , .
- 3Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS-IPS). Headache. 2010;50:937-942., , , et al.
- 43Coma after greater occipital nerve blockade in a patient with previous posterior fossa surgery. Headache. 2012. Epub ahead of print 18 Dec 2012., .
- 44Corticosteroids conversion calculator. http://www.globalrph.com/corticocalc.htm. Accessed January 29, 2012..